Clinical Trial Update: Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD. [Phase 3]

View source ↗

Summary

Phase 3 trial found that adding liraglutide to a calorie-restricted diet led to greater weight loss and reduced risk factors for type 2 diabetes and cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity
• Pre-diabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Stanford University | Conditions: Pre-diabetes, Older Adults | Phase 3 | Status: COMPLETED | Results posted: 2017-04-21